FR941005-2-00104 FR941005-2-00072 Manufacturer of Controlled Substances; Application Pursuant to ยง1301.43(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on September 8, 1994, Knoll Pharmaceuticals, 30 North Jefferson Road, Whippany, New Jersey 07981, made application to the Drug Enforcement Administrtation (DEA) for registration as a bulk manufacturer of the Schedule II controlled substance Hydromorphone (9150). Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the above application and may also file a written request for a hearing thereon in accordance with 21 CFR 1301.54 and in the form prescribed by 21 CFR 1316.47. Any such comments, objections, or requests for a hearing may be addressed to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than (30 days from publication). Dated: September 28, 1994. Gene R. Haislip, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 94&hyph;24575 Filed 10&hyph;4&hyph;94; 8:45 am] BILLING CODE 4410&hyph;09&hyph;M
